FCA Corp’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CGTX
C
CM
FCA Corp's CGTX Position: Q3 2026 in Review
FCA Corp held its Cognition Therapeutics (CGTX) position steady in Q3 2026 at 52,536 shares worth $50.4K. The position accounts for 0.01% of the portfolio, ranked #194.
FCA Corp first reported a position in CGTX in Q1 2023 and has held it in 15 quarters since. The position peaked at $102K in Q1 2023. 78 funds tracked by Wall St. Rank hold CGTX as of Q3 2026.
- FCA Corp held 52,536 shares of Cognition Therapeutics worth $50.4K as of Q3 2026.
- FCA Corp left its Cognition Therapeutics share count unchanged in Q3 2026.
- Cognition Therapeutics made up 0.01% of FCA Corp's portfolio in Q3 2026, its #194 holding.
- FCA Corp first reported a position in Cognition Therapeutics in Q1 2023 and has held it in 15 quarters since.
- FCA Corp's Cognition Therapeutics position peaked at $102K in Q1 2023.
- 78 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q3 2026.
Based on FCA Corp's 13F filing for Q3 2026, filed 12 Nov 2026.